DataMeds AI, Inc.
MEDS- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0002030763
No open-market purchases or sales by DataMeds AI, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $160.6K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding DataMeds AI, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 6 | 16 | +10 |
| Shares | 612.3K | 4.39M | +3.78M (+617.0%) |
| Value | $593.0K | $3.89M | +$3.30M (+556.7%) |
New holders (13)
Institutions that held DataMeds AI, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Heights Capital Management, Inc | 2,917,078 | $2.59M | 0.82% |
| Vanguard Group Inc | 739,241 | $655.7K | 0.00% |
| Geode Capital Management, LLC | 269,213 | $238.8K | 0.00% |
| ORG Wealth Partners, LLC | 100,000 | $88.7K | 0.02% |
| State Street Corp | 97,300 | $86.3K | 0.00% |
| Northern Trust Corp | 72,004 | $63.9K | 0.00% |
| UBS Group AG | 42,666 | $37.8K | 0.00% |
| XTX Topco Ltd | 35,950 | $31.9K | 0.00% |
| Tower Research Capital LLC (TRC) | 16,521 | $14.7K | 0.00% |
| Jump Financial, LLC | 16,200 | $14.4K | 0.00% |
| Citigroup Inc | 2,259 | $2.00K | 0.00% |
| Bank of America Corp | 250 | $222 | 0.00% |
| Morgan Stanley | 10 | $9 | 0.00% |
Sold out (3)
Institutions that held DataMeds AI, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Millennium Management LLC | 569,570 | $551.7K |
| Renaissance Technologies LLC | 10,200 | $9.88K |
| Advisor Group Holdings, Inc. | 1,000 | $960 |